PMID- 17440246 OWN - NLM STAT- MEDLINE DCOM- 20070712 LR - 20070418 IS - 0031-9155 (Print) IS - 0031-9155 (Linking) VI - 52 IP - 9 DP - 2007 May 7 TI - Improvement of field matching in segmented-field electron conformal therapy using a variable-SCD applicator. PG - 2459-81 AB - The purpose of the present study is to demonstrate that the use of an electron applicator with energy-dependent source-to-collimator distances (SCDs) will significantly improve the dose homogeneity for abutted electron fields in segmented-field electron conformal therapy (ECT). Multiple Coulomb scattering theory was used to calculate and study the P(80-20) penumbra width of off-axis dose profiles as a function of air gap and depth. Collimating insert locations with air gaps (collimator-to-isocenter distance) of 5.0, 7.5, 11.5, 17.5 and 19.5 cm were selected to provide equal P(80-20) at a depth of 1.5 cm in water for energies of 6, 9, 12, 16 and 20 MeV, respectively, for a Varian 2100EX radiation therapy accelerator. A 15 x 15 cm(2) applicator was modified accordingly, and collimating inserts used in the variable-SCD applicator for segmented-field ECT were constructed with diverging edges using a computer-controlled hot-wire cutter, which resulted in 0.27 mm accuracy in the abutted edges. The resulting electron beams were commissioned for the pencil-beam algorithm (PBA) on the Pinnacle(3) treatment planning system. Four hypothetical planning target volumes (PTVs) and one patient were planned for segmented-field ECT using the new variable-SCD applicator, and the resulting dose distributions were compared with those calculated for the identical plans using the conventional 95 cm SCD applicator. Also, a method for quality assurance of segmented-field ECT dose plans using the variable-SCD applicator was evaluated by irradiating a polystyrene phantom using the treatment plans for the hypothetical PTVs. Treatment plans for all four of the hypothetical PTVs using the variable-SCD applicator showed significantly improved dose homogeneity in the abutment regions of the segmented-field ECT plans. This resulted in the dose spread (maximum dose-minimum dose), sigma, and D(90-10) in the PTV being reduced by an average of 32%, 29% and 32%, respectively. Reductions were most significant for abutted fields of nonadjacent energies. Planning segmented-field ECT using the variable-SCD applicator for a patient with recurrent squamous cell carcinoma of the left ear showed the dose spread, sigma, and D(90-10) of the dose distribution in the PTV being reduced by an average of 38%, 22% and 22%, respectively. The measured and calculated dose in a polystyrene phantom resulting from the variable-SCD, segmented-field ECT plans for the hypothetical PTVs showed good agreement; however, isolated differences between dose calculation and measurement indicated the need for a more accurate dose algorithm than the PBA for segmented-field ECT. These results confirmed our hypothesis that using the variable-SCD applicator for segmented-field ECT results in the PTV dose distribution becoming more homogenous and being within the range of 85-105% of the 'given dose'. Clinical implementation of this method requires variable-SCD applicators, and the design used in the present work should be acceptable, as should our methods for construction of the inserts. Dose verification measurements in a polystyrene phantom and the recommended improvements in dose calculation should be appropriate for quality assurance of segmented-field ECT. FAU - Richert, John D AU - Richert JD AD - Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, LA 70803-4001, USA. FAU - Hogstrom, Kenneth R AU - Hogstrom KR FAU - Fields, Robert S AU - Fields RS FAU - Matthews, Kenneth L 2nd AU - Matthews KL 2nd FAU - Boyd, Robert A AU - Boyd RA LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20070410 PL - England TA - Phys Med Biol JT - Physics in medicine and biology JID - 0401220 SB - IM MH - Carcinoma, Squamous Cell/radiotherapy MH - Ear Neoplasms/radiotherapy MH - *Electrons MH - Humans MH - Neoplasm Recurrence, Local MH - Radiotherapy, Conformal/instrumentation/*methods EDAT- 2007/04/19 09:00 MHDA- 2007/07/13 09:00 CRDT- 2007/04/19 09:00 PHST- 2007/04/19 09:00 [pubmed] PHST- 2007/07/13 09:00 [medline] PHST- 2007/04/19 09:00 [entrez] AID - S0031-9155(07)30911-1 [pii] AID - 10.1088/0031-9155/52/9/009 [doi] PST - ppublish SO - Phys Med Biol. 2007 May 7;52(9):2459-81. doi: 10.1088/0031-9155/52/9/009. Epub 2007 Apr 10.